RespireRx Pharmaceuticals Inc (CE) (RSPI) Share Price

Yeah. But going through the OTCID new market rules effective July 1st 2025, it makes some sense that there may not have been much for them to benefit fixing their situation, comply to the existing system, and exit the expert market back into anything else before July 1st. If they’re up to sorting anything out, getting it done so it comes on then actually doesn’t sound too crazy.

8-k is what they release when they get funding they don't press pumps first. Another reason why I invested in them.

"So give them 2 more weeks to hopefully wrap up the loose ends , post the 8k , 30-45 days to be reinstated on the new OTC ."
Why do they need to post an 8k and what would you expect to be in it?

Yeah it's in bad shape. Needs to file. Needs to get TA Verified. Best to file a Form 15 but nobody wants to listen. Its going to end up revoked with a string of digits showing -100%

Still showing EM on etrade

Not sure what tier they would start on, with the new rules I think they will be watching alittle closer at least when rules starts in July . I think they probably have everything for the most part ready and will send over asap , once audit is done I dont think they are using the non reporting route with a lawyers letter to get going. I think they need things to be audited for all the deals they will be entering into. Yes it could be a great XMAS for all of us that have held strong. GLTA

Bid Ask?

Yeah, so given that they need small funding inked, filings filed and 30 day review to be OTCID, then I would guesstimate into August before trading... Now once the filings are filed will it go on pink limited tier as an intermediate before any OTCID review is finalized? Is it possible given those steps that some brokerages begin quoting RSPI prior to OTCID? Either way, I can see interest build while on the EM as these steps signal the ability to roll into the larger catalysts...

I think the bigger potential catalysts such as BP partnership, venture funding EndeavourRx, in-licensing, IND submissions, clinical trial initations, collaborations will all logically come after the above all settles out. These catalysts set the stage for an exciting 6 months+ coming up and positioning for larger leaps in ROI as phase 1/2 clinicals for multiple indications eventually get underway...

No usually for a company to file to become current or tradable again the review usually takes 30-45 days. I have seen it take less time but that is what they state it will take to review. If RSPI has been in touch and have kept them appraise of their sisusation I think that might move it quickier , but who knows about that and how many other companies are jocking over the new changes taking place July . All a guessing game until they start dropping what they have been doing over the last 4 months, but I think it will be good and worth the wait we have gone thru. GLTA

You mention the 30-45 days time frame. Is that what you think to complete all the filings and whatever paperwork required to get approved for trading again?

They have had so much time to get filings prepped and audit information ready to check those boxes that it should not be a long process. Unless there is a higher level audit taking place for acquisition, etc, but again doesn't seem that perplexing given all this time they have had. I don't know what the process of moving from EM back to OTCID looks like, is it simple paperwork then approval? Seems like that could be done in days not weeks... Regardless, the point will be that they are finally moving FORWARD and with that could easily come a dozen individual updates and significant valuation reset that rivals other pharma equities that gained 100's of million in valuation practically overnight, and most of those come with major funding agreements to support the new valuations; which sounds exactly what has been going on here as well....

Agree. Just getting some minor funding in place to handle the SEC filings and more, getting current and trading again as well as locking in additional grant funding, applying for more grants will generate interest well into pennies.. I am specuulating and logically from the HEAL program there is likely major funding or partnership brewing for KRM-ll-81... That could easily take these prices into the dimes and quarters range....

Part of me thinks there might be a move to get off the OTC completely, but maybe RSPI will move some of the assets to another exchange via RM/M&A, etc..... and just own a huge equity stake like they do with Resolution Rx which also was supposedly to be slated to trade on another exchange, but the entire platform is stagnated for some reason, my guess has been cannibas/cannibas derived regulations in the USA, but no idea with that one...

That is what the board should be about , helping each other thru the good and bad times GLTA

I'm following. Understandable. Tremendously am appreciative of how u been remaining in contact on our behalf. Once we make it on the other side of this storm let's all crack open bottle don lol. I won't forget all u held the line here in this chat lol! GLTA god speed!

I am thinking since he first pointed to end of May or roll into 1st of June they had to be pretty close. So give them 2 more weeks to hopefully wrap up the loose ends , post the 8k , 30-45 days to be reinstated on the new OTC . Remember I asked him what the plan was for the new OTC rules awhile back and he seemed to be caught off guard and said he had to look into. I think this is a driving factor in getting things rolling, maybe they got relief from the trade comminision about being on the EM with no mention or removal. Just thinking out loud about the TC and turning a blind eye until the new rules take place. Okay back to timing I think they will be returned to the trading of OTC mid July due to the time to review their application and holiday mixed in again just thinking out loud and could be totally off base. All is depending on how fast they get the details finialized and 8K out. I think they are close
I am holding the 15m I have tightly GLTA

Y do think following July 4th we will get a update? Just curious about your evidence towards ur conclusion. GLTA I own 7m shares not planning on selling we waited this long might as well see it through. Either we lose all of it or see 10x+ plus gains from these levels imo

There Is Now A Call For President Trump To Ban Naked Short Selling
Understand the dangers of naked short selling and why banning it could be a top priority for Trump's administration.

https://franknez.com/there-is-now-a-call-for-president-trump-to-ban-naked-short-selling/?utm_source=grow&utm_medium=email&utm_campaign=automailer&utm_content=rec

On June 9, 2025, Newsmax published an article by Dennis Kneale titled “Trump Can Help Investors by Banning ‘Naked Shorts,'” which argues for a decisive executive action by President Donald Trump to curb naked short selling—a practice that destabilizes the financial markets and harms retail investors.

Today we’re going over the key points of Kneale’s argument, the mechanics and impact of naked short selling, and why banning it could be a significant policy priority for the Trump administration in 2025.

By addressing this issue, the administration could bolster investor confidence, stabilize markets, and align with its broader economic agenda of fairness and transparency.

Understanding Naked Short Selling
https://franknez.com/big-changes-underway-to-the-stock-market-regarding-naked-short-selling/


Naked short selling occurs when traders sell shares of a company they do not own and have not borrowed, betting that the stock price will fall before they need to deliver the shares.

Unlike traditional short selling, where shares are borrowed before being sold, naked short selling involves selling “phantom” shares that may not exist in the company’s float.

This practice can artificially inflate the supply of shares, driving down stock prices and cause significant market distortions

They probably got their news from here. If people hold tight for awhile ths MM won't get anything at this low price. The time is coming I think it will be after July 4 that this is tradable again . Can't come soon enough. I think .05-.10 trading range will be here soon with the news they are pointing to. GLTA

TY for the update

From today:

Jeff:
Any new word on funding or getting us off the EM? Hope you are well.
Tom

Nothing to report publicly just yet, but we believe, soon. Funding, grants and financial statements which is necessary (plus audits) to get off the EM.

JM

Probably just for starters…. IND submissions, clinical trials, in licensing, collaborations, BP partnerships…

They have talked about funding for EndeavourRX, but also funding for Respire to get off EM and administrative..

Funding--++-Grants and getting off EM means a terrific run on price! Question is who is funding and what grants?

Yes he is good at resonding , may not be what we want to hear at the time but he doesn't duck a question. That is why I have been loading the cash account waiting for the exit of EM. I am hoping to get another 5m before the price goes up in a hurry. GLTA

Yeah I give him props for that basically whole reason I didn't sell was bc when we was going to EM I got him on the phone and he reassured his commitment to righting the ship and stated his clear incentive how his salary is tied to making this work and if they wanted to scam insinuated how the debt and conversion would've been setup and  conducted differently which I agree with. Could've diluted to death for a quick pay day. Hopefully we are at the finish line. GLTA!

Jeff has always responded to me within a day.

Atleast he isn't ducking communication that's a positive. We obviously going through turbulence one can only hope we near passing the bleak dusk

From today:

Jeff:
Any new word on funding or getting us off the EM? Hope you are well.
Tom

Nothing to report publicly just yet, but we believe, soon. Funding, grants and financial statements which is necessary (plus audits) to get off the EM.

JM

Ever heard of the San Diego company Cue Health? Sounds verrrrrrry familiar.

New market report just released mentioning RSPI

Global Sleep-Wake Disorder Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Page: 131
Published Date: 27 May 2025

Market segment by players, this report covers
Jazz Pharmaceuticals
Koninklijke Philips N.V.
Merck KGaA
Neurocrine Biosciences
RespireRx Pharmaceuticals Inc.
Medtronic PLC
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals Inc.
Jazz Pharmaceuticals
Koninklijke Philips N.V.
Merck KGaA
Neurocrine Biosciences
RespireRx Pharmaceuticals Inc.
Medtronic PLC
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals Inc.


https://www.globalinforesearch.com/reports/2772958/sleep-wake-disorder

I'm showing an ask and a bid this morning. Been over a year

Well, folks... I have been following a startup biotech here in San Diego that has a pipeline not even close to that of RSPI, no molecules in clinical trials, Preclinicals still going on with the expected clinical for one lead molecule next year. They recently got a 25 M venture capital input and expect to do an IPO later this year. Now we have RSPI with a pipeline that makes the afore mentioned company's pipeline look infantile in comparison. It sure is looking rosy for us who managed to have large positions in RSPI.

Pharma/Biotech are a different breed. There are so many examples whether OTC or NASDAQ where once all arrangements are made for (license, partnership, sale) that these equities add 100's of million in market value within a week or less. I expect nothing less here. The science and preclinical postioning/efforts are compelling and with a legitamate chance to be transformative medicine. Good Luck to All.

Ah a reminder.. "It has a filing obligation"

Yes it does and there is zero excuse for a company with this high caliber of assets and strong historical compliance record now obviously negotiating arrangements to get multiple candidates into clinical trials. Could have and should have easily stayed current while still conducting ALL the activities they listed in shareholder letter. But sometimes it takes connecting the dots and some logic to identify contrarian indicators.

The ridiculous prints of 1 share or 5 share transactions make no sense and I always assumed it was entities cleaning up their books/positions often times in advance of significant happenings with the equity.

But fishing with a reel and a bobber is stress free, even if the boats with the 40' nets came by a long time ago...

9.95 a trade. I would not be buying this.

It has a filing obligation

Ya it’s $10 a trade… some days I get today’s small basket; other days many multiples of that. It’s adding up and I’m increasingly feeling that I’m not drinking the coolaide on this one… I hope. Thanks all for your D and D on this people.

How do you know? 

1 share traded at 0.0018, from 0.0006, that would be 300%. So It was ignored. Or is it one of those semaphores?

And Daniel Radin graduated from his MD/PhD program. Well done you!

FWIW, Both StockTwits and X just had a significant step up in $RSPI chatter/gossip. Something about Market Makers looking to accumulate some / Impending news coming.

At least it’s something that never happened before, so verify.

Royal Bank of Canada investing has a flat fee of 9.95$ per transaction, up to a certain number, after which they’re free. But it’s a stupidly big number, and I won’t look it up because there’s no point.

What kind of commission does one have to pay on a $158 trade?

Yes and one day we might have a run like this from yesterday KLTO yesterday's .47 to today's high of 3.91

… well this here Canadian keeps chipping away …. Another 258k pick today. Long and strong.

not true, i still hold ENZC so i never dashed

Yep. Multiple candidates, many indications heading towards multiple clinical trials.. that fits the complexity and multiple parties expectations…. I expect a large funding deal to surface sooner than later here..,

How they exit the EM will be interesting…. But for sure this has all the ingredients to rival some of the historic otc pharma equities..

Merger, licensing agreements and or selling a valuable asset. OTC is last of their worries IMO.

Given all this time on the EM one has to wonder what is taking so long to come up with some minor funding to complete filings and back to OTC before becoming very active in their shareholder letter goals and activities. I am starting to lean that they are not coming back to the OTC. They could just move the entirety of the neuromodulator program to the NASDAQ via RM/M&A.... With possibly 3 or 4 candidates heading to clinicals in the next few years, all very lucrative opportunities and unmet markets, wouldn't there be some logic to such a move where institutional/BP entities can more readily partner and support? Could this be where they are kicking the can too??

What is the point of these weird single digit lot share sells... Is this some bookkeeping by market participants?

Nah it hit 0004 like in November lol

Well it sounds like there are all kinds of negotiations and planning going on in the background that are mostly out of company control.. logically more in the hands of funding sources and BP level resources to conduct clinicals. Would make sense with KRM-ll-81 in the HEAL program stage where they submit IND and start phase 1 as well as same candidate where they worked with consultants for grant funding to get to similar IND submission for epilepsy. And they have phase 2 money for SCI and likely want to get ADHD clinical going as well…. Again multiple high caliber assets heading into clinicals… I can imagine the complexity..

And probably these shares are extremely valuable…. So some hedged positions likely want to accumulate significantly on the long side. Would only take some sophisticated or Canadian interest to drive this..